Vanguard Capital Management
TWST icon

Vanguard Capital Management’s Twist Bioscience TWST Stock Holding History

Vanguard Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278M Buy
2,699,280
+60,236
+2% +$3.92M 0.01% 953
2026
Q1 		$125M Buy
+2,639,044
New +$118M ﹤0.01% 1345

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Capital Management's TWST Position: Q2 2026 in Review

Vanguard Capital Management increased its Twist Bioscience (TWST) stake by 2.3% in Q2 2026, buying an estimated $3.92M and bringing the position to 2,699,280 shares worth $278M. The position accounts for 0.01% of the portfolio, ranked #953.

Vanguard Capital Management first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Vanguard Capital Management held 2,699,280 shares of Twist Bioscience worth $278M as of Q2 2026.
  • Vanguard Capital Management bought 60,236 Twist Bioscience shares in Q2 2026, an estimated $3.92M.
  • Twist Bioscience made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #953 holding.
  • Vanguard Capital Management first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.